Korea Bio-Gen Co.Ltd (318000) — Free Cash Flow Generation Index
Korea Bio-Gen Co.Ltd (318000) has a Free Cash Flow Generation Index of 0.93x as of September 2025. Free cash flow of ₩1.72 Billion represents 1% of operating cash flow (₩1.85 Billion). See Korea Bio-Gen Co.Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Korea Bio-Gen Co.Ltd Free Cash Flow Generation Index (2017–2024)
Historical FCF Generation Index trend for Korea Bio-Gen Co.Ltd across 8 annual periods. Explore Korea Bio-Gen Co.Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Korea Bio-Gen Co.Ltd (2017–2024)
Year-by-year Free Cash Flow Generation Index for Korea Bio-Gen Co.Ltd. For the full company profile including market capitalisation, see 318000 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.19x | ₩-826.14 Million | ₩4.29 Billion | ₩5.12 Billion | ▼ -125.9% |
| 2023 | 0.74x | ₩7.05 Billion | ₩9.47 Billion | ₩2.42 Billion | ▲ +301.2% |
| 2022 | -0.37x | ₩-617.53 Million | ₩1.67 Billion | ₩2.29 Billion | ▼ -255.8% |
| 2021 | 0.24x | ₩734.39 Million | ₩3.09 Billion | ₩2.36 Billion | ▼ -64.1% |
| 2020 | 0.66x | ₩1.71 Billion | ₩2.58 Billion | ₩872.46 Million | ▲ +658.8% |
| 2019 | 0.09x | ₩266.28 Million | ₩3.05 Billion | ₩2.55 Billion | ▼ -93.9% |
| 2018 | 1.42x | ₩2.83 Billion | ₩1.98 Billion | ₩840.93 Million | ▼ -8.8% |
| 2017 | 1.56x | ₩2.16 Billion | ₩1.38 Billion | ₩777.66 Million | — |